AJP - Regu AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 281: R1975-R1985, 2001;
0363-6119/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veldhuis, J. D.
Right arrow Articles by Pincus, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veldhuis, J. D.
Right arrow Articles by Pincus, S. M.
Vol. 281, Issue 6, R1975-R1985, December 2001

Impact of pulsatility on the ensemble orderliness (approximate entropy) of neurohormone secretion

J. D. Veldhuis1, M. L. Johnson1,2, O. L. Veldhuis1, M. Straume1, and S. M. Pincus3

Departments of 1 Internal Medicine and 2 Pharmacology, General Clinical Research Center, Center for Biomathematical Technology, University of Virginia School of Medicine, Charlottesville, Virginia 22908; and 3 Guilford, Connecticut 06437


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Regular patterns of neurohormone secretion are driven by underlying pulsatile and subordinate (feedback sensitive) dynamics. Measures of time-series orderliness, e.g., the approximate entropy (ApEn) statistic (Pincus SM. Proc Natl Acad Sci 88: 2297-2301, 1991), vividly discriminate pathological and physiological patterns of hormone release. To investigate how specific pulsatility features impact regularity estimates, we have examined the sensitivity of the ApEn metric to systematic variations in the frequency, amplitude, and half-life of simulated neurohormone pulse trains (Veldhuis JD, Carlson ML, and Johnson ML. Proc Natl Acad Sci 84: 7686-7690, 1987) and compared the impact of a high vs. low baseline luteinizing hormone (LH) pattern regularity state mimicking the normal female luteal phase and the young male, respectively. Shortening the interpulse interval length elevated ApEn in both pulsatility models, thereby signifying greater ensemble series irregularity. The frequency sensitivity of ApEn was robust to several complementary renditions of ApEn and to variations in experimental uncertainty, basal (nonpulsatile) LH secretion, and secretory burst amplitude. ApEn rose with increasing hormone half-life, especially in the face of low baseline variability emulated by midluteal LH secretion profiles. High variability of secretory burst amplitude, pulse duration, or interpeak intervals increased ApEn in the more orderly femalelike construct; in the highly irregular malelike LH pulse model, these variability changes had little effect on ApEn. In summary, the ensemble regularity statistic, ApEn, quantifies unequal pattern orderliness in neurohormone pulse trains with minimal dependence on mean pulse amplitude, interpulse baseline, or (subthreshold) sample uncertainty. Thus ApEn monitors changing secretory event frequency and interpulse variability with sensitivity to starting pattern regularity, providing a mechanistic linkage between model evolution and statistical change.

hormone release; statistics; patterns; biomathematics


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

ENDOCRINE GLANDS direct remote target tissues via pulsatile hormone signals (5, 43). Pulsatility is modulated by feedforward and feedback activity within the neuroendocrine axis (12-14), thereby conferring physiological regulation (46). Such adaptive complexity makes the consequences of altered neurohormone pulsatility and feedback control difficult to calibrate. Indeed, in some pathophysiological contexts, pulsatility quantitation itself becomes challenging (7, 39, 44, 45, 62).

Pattern regularity quantification provides a complementary perspective of coupled systems (26, 30, 31). For example, neuroendocrine tumors that disrupt within-axis control markedly impair the serial reproducibility (or subpattern orderliness) of hormone secretion, as quantified by independently validated regularity statistics (7, 42). One such metric, approximate entropy (ApEn) (20), discriminates male and female growth hormone (GH) secretory pattern regularity (8, 17, 24) and identifies more disorderly hormone release profiles in healthy aging individuals (10, 16, 31, 45, 53). However, the degree to which altered feedback and pulse pathophysiology direct differences in ensemble pattern orderliness has not been determined by explicit mathematical model analysis. One recent analysis begins to address this issue by examining the relationship between pulsatility and regularity changes in a basic simulation model comprising a convolved (triangular) input signal and an (exponential) impulse-response function (41).

To explore further how distinct pulsatility features impact the ensemble orderliness of neurohormone time series, we have implemented a broad multiparameter model, which emulates the well-ordered luteinizing hormone (LH) pulse trains typically reported in midluteal-phase women (1) and highly irregular LH pulsing of young men (43). Thereby, we examine the impact of the model platform (e.g., low- vs. high-irregularity ApEn baseline profiles) on ApEn sensitivity to within-series pulsing variability. Our findings indicate the utility of a composite regularity measure in quantifying complex output differences due to specific pulsatility changes. These insights should aid in interpreting potential feedback changes within a neuroendocrine axis independently of pulsatility distinctions and in providing a mechanistic interpretation to ApEn findings in hormone secretory patterns.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Convolution integral. Simulated pulsatile neurohormone time series were created exactly as described previously (47, 50, 52). Briefly, trains of discrete pulses are modeled as the integrated output of a secretion function, S(z), convolved with an elimination function, E(t - z) (47, 50). S(z) is defined as the sum of an underlying basal time-invariant (nonpulsatile) secretion rate and a series of secretory bursts of fixed half-duration [= 2.354 × the standard deviation (SD) of a Gaussian waveform] and variable amplitudes Ai occurring at times Ti. Here, Ai and Ti are independently and identically distributed random normal variables. Variability of pulse amplitude and interval length was defined by corresponding parameter-specific coefficients of variation (CV = SD/mean × 100%) (52, 55). The E(t - z) function was approximated as a monoexponential elimination process, taken arbitrarily as 50 min (or otherwise as noted) to emulate nominal human LH kinetics (48). The convolution product, S(z) · E(t - z), was integrated analytically at 0.1-min intervals (52). The resultant time series were discretized to simulate a typical 10-min (or other as indicated) sampling frequency. To incorporate procedural uncertainty, experimental variance was superimposed additively on each synthetic sample replicate value as independently and identically distributed random Gaussian noise at a specified CV (initially 8%) with a minimum (absolute) replicate SD of 0.1 (arbitrary) concentration units (IU/l). Data were synthesized as duplicate within-sample values, the means of which were appraised by ApEn analysis. Any (rare) predicted negative hormone concentrations were regenerated with another iteration. Time series were created for 15 slow-phase half-lives before the resultant 1,440-min (or longer) time segment was analyzed.

One hundred pulse-train realizations with different random seeds were constructed for each ApEn calculation of LH profiles mimicking the midluteal phase of the normal human menstrual cycle (1) and of the healthy young male (43). Corresponding convolution integral parameter sets were used to emulate the high- and low-pulsing regularity states. Common parameters in both models included a half-life of 50 min, mean secretory burst amplitude of 0.3 IU · l-1 · min-1, and a fixed secretory pulse half-duration of 11.77 min (SD = 5.0 min). The mean interpulse interval length was 360 min (±0% CV) in the femalelike and 60 min (±30% CV) in the malelike LH profiles, and additive independently and identically distributed noise was ±2.0% and ±8.0%, respectively. Basal (nonpulsatile) time-invariant LH concentrations were defined as 1.0 (female) and 0 IU/l (male) in the simulated profiles. The foregoing parameter choices approximate the published attributes of LH pulse trains in healthy young midluteal-phase women and normal men (6, 40, 43, 51, 59).

ApEn analysis. ApEn is a model-free regularity measure that quantifies the orderliness of subordinate patterns in mathematical sequences and empirical time series (20, 26, 30). ApEn comprises a two-parameter family of statistics, ApEn(m,r), with m a run length and r a de facto tolerance width (see Refs. 24 and 31 for practical examples). Normalized ApEn parameters of m = 1 and r = 20% of each series SD were used here, as previously described for various neurohormone profiles of this length (7, 10, 24, 57).

The ApEn statistic monitors sample-by-sample pattern irregularity and is thus distinguished from conventional analyses of pulsatility or circadian rhythmicity. Higher ApEn values denote greater irregularity (or process randomness) of successive measurements, as reported for tumoral time series (7, 39, 44, 45, 62); GH patterns in boys during mid- to late puberty and prepubertal children administered sex steroid hormones (4, 57); GH secretion in females compared with males (8, 24, 57); and ACTH, LH, GH, cortisol, testosterone, and insulin time series in aging humans (8, 10, 16, 31, 53).

The distribution of empirically "random" (maximal) ApEn values was determined by 1,000 random shuffles of ordered sample values within each time series. Thereby, ApEn of each "observed" (unshuffled) time series was also evaluated as a mean ratio of observed-to-random ApEn and as a calculated z score (number of SDs) removed from an empirically maximally random ApEn value (58).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Figure 1 illustrates simulated femalelike (Fig. 1A) and malelike (Fig. 1B) serum LH concentration profiles. More extended 10-min discretized pulse trains are shown for females to highlight the behavior of infrequent pulses. Simulation parameter choices included a mean LH secretory burst amplitude of 0.3 IU · l-1 · min-1 (±0% CV in the female and ±30% CV in the male), a 0 or 1.0 IU/l basal (female and male) LH concentration, a fixed half-life of 50 min, and 2 or 8% superimposed experimental uncertainty (female and male, respectively) (see METHODS). Higher mean pulse frequencies increased pattern irregularity visually in both sets of simulated time, as quantified further by ApEn analysis. The de facto dependence of ApEn on enforced LH pulse frequency is exemplified in Fig. 1C, wherein a gonadotropin-releasing hormone (GnRH)-deficient patient received fixed intravenous GnRH pulses at three different intervals (data provided by Drs. F. C. Hayes and W. F. Crowley, Jr.).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 1.   Illustrative computer-assisted simulations of well-ordered vs. baseline-irregular luteinizing hormone (LH) pulse trains corresponding to midluteal femalelike (A) or young malelike (B) secretory profiles, respectively, driven at various pulse frequencies (or the reciprocal indicated mean interpulse intervals). Time series are presented as 10-min discretized data generated by integration (over 0.1-min intervals) of the convolution product of a multiparameter secretory (impulse) and monoexponential elimination (impulse response) function. The secretory model consisted of punctuated temporally dispersed (Gaussian) secretory bursts of mean amplitude 0.3 IU · l-1 · min-1 (±0% in the female and ±30% in the male) of a fixed half-width of 11.77 min (SD = 5.0 min). Elimination kinetics comprised single-exponential decay corresponding to a nominal hormone half-life of 50 min. Sample experimental uncertainty (vertical bars) was superimposed additively [coefficient of variation (CV): female, 2%; male, 8%]. Interpulse (basal) serum LH concentrations were defined as 1.0 IU/l or 0 in the female and male profiles, respectively (see METHODS). C: influence on LH approximate entropy (ApEn) of progressively varying exogenous gonadotropin-releasing hormone (GnRH)-driven LH pulse frequencies in a GnRH-deficient subject. Q45, Q60, and Q180 denote the GnRH pulse-injection intervals.

Figure 2 summarizes the impact on ApEn of varying interpulse intervals(s) in the malelike (baseline more irregular) LH pulse stimulation model using 100 datasets (realizations) per ApEn estimate, on the basis of preliminary comparisons among 10, 30, 100, 300, and 1,000 realizations (not shown). Discretized time series were evaluated at ApEn parameters of m = 1 and m = 2 and r = 20% (see METHODS). In particular (at constant interpulse variability of ±30%), a higher mean pulsing frequency or, equivalently, a lower interpulse interval consistently reduced ensemble series regularity. We see this in three ways: 1) a rise in ApEn (Fig. 2, top); 2) an increase in the mean ratio of observed-to-random ApEn values (Fig. 2, middle); and 3) a fall in the ApEn z score, denoting the number of SDs by which an observed ApEn value diverged from empirically maximally random ApEn (Fig. 2, bottom). The femalelike (more orderly baseline) LH pulse simulation model analogously showed strong ApEn dependence on mean pulsing frequency (not shown).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Impact of varying mean interpulse interval length on the ApEn(m,r) estimate of time-series ensemble regularity. Pulse trains simulating malelike LH time series were created as described in Fig. 1. ApEn was calculated at r = 20% and m = 1 and m = 2 (top). The ApEn ratio was computed as the mean ratio of each observed ApEn value to that of 1,000 randomly shuffled representations of the same series (middle). The ApEn z score was defined as the number of SDs that each observed ApEn value was removed from empirically maximally random (shuffled) ApEn (bottom) (see METHODS). Mean interpulse interval lengths are indicated on the y-axis (logarithmic scale). Each ApEn data point is the mean ± SD (N = 100 simulated series).

The foregoing relationships were evident for ApEn vector lengths of m = 1 and m = 2 and for several appropriate choices of the ApEn threshold (r values, Fig. 3A). Statistically inappropriate choices of r (e.g., 2 or 200%) and progressive undersampling of the data series (e.g., a 30-, 60-, or 90-min sampling interval) corrupted the sensitivity of ApEn to changes in mean pulse frequency (Fig. 3B).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Influence on ApEn(m,r) of systematically varying the threshold parameter r from 2 to 200% (A) and the apparent sampling interval from 5 to 120 min (B) for simulated malelike LH pulsing profiles exhibiting a spectrum of mean LH interpulse intervals from 15 to 120 min.

Figure 4 depicts the influence on ApEn of the convolved hormone elimination rate based on simulated femalelike and malelike LH profiles (half-life, Fig. 4A). More prolonged LH half-lives elevated ApEn for both gender simulations. ApEn was largely independent of mean secretory burst amplitude (IU · l-1 · min-1, Fig. 4B), whereas increasing secretory burst SD (min, Fig. 4C) reduced ApEn. ApEn was also unaffected by changes in underlying basal (time invariant, nonpulsatile) LH concentrations (0.03, 0.1, 0.3, and 1.0 IU/l, not shown).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Impact of systematic variations in mean hormone half-life (A) and secretory burst amplitude (B) and SD (C) on the estimation of ApEn(m,r) in the orderly femalelike LH pulsatility model (A-C, top) and the highly irregular malelike LH pulsatility model (A-C, bottom). Data are presented otherwise as described in legend of Fig. 2.

Figure 5 depicts the effect on ApEn of heightening the variability of interburst interval, secretory burst amplitude, and burst half-duration over a broad range of CVs at otherwise fixed mean parameter values (see METHODS). Higher variability of pulse amplitudes elevated ApEn in the more orderly femalelike LH simulations (Fig. 5A), yet it had very small effect on ApEn for small and moderate variability and somewhat reduced ApEn given very high (30%-100% CV) variation in the highly irregular LH release malelike setting (Fig. 5B). Figure 6 illustrates typical simulation outputs. Thus the degree of baseline irregularity (low vs. high) modulates ApEn responses to markedly altered parameter variability.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of changing the degree of variability (CV) of individual pulse attributes, i.e., interpulse interval length, secretory burst amplitude, and SD, on ApEn(m,r). A: more orderly femalelike LH pulse model typical of the midluteal phase of the normal human menstrual cycle. B: more irregular malelike LH pulse model (see METHODS).



View larger version (49K):
[in this window]
[in a new window]
 
Fig. 6.   Illustrative impact of interpulse interval variability (expressed as a CV, i.e., 0, 10, 30, and 100%) on the simulation outputs of LH profiles for femalelike (A) and malelike (B) models (see METHODS).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The present detailed pulse simulation analyses delineate baseline-, sample uncertainty-, and pulse amplitude-independent (i.e., scale invariant) properties of the ApEn statistic and document strong pulse frequency, hormone half-life, and parameter variability sensitivity of this regularity metric. Comparisons between pulse models emulating low and high baseline irregularity of LH secretory profiles typifying the human midluteal phase in the female and the normal young male, respectively, unveiled an impact of intrinsic model structure on ApEn evolution to pulse perturbations.

The relative independence of ApEn from variations in baseline and pulse amplitude in simulated neurohormone pulse trains is consistent with the theoretically predicted scale and translation invariance of this regularity measure in simpler coupled numerical systems (19, 29, 30). ApEn contrasts were also largely insensitive to underlying random experimental uncertainty (noise) below the ApEn threshold. The foregoing three empirically validated features of ApEn would suggest the utility of this metric in comparing complex neurohormone time series with nonidentical pulse amplitudes, baselines, and (subthreshold) noise levels.

Further simulations established that mean pulsing frequency governs ensemble orderliness of the neurohormone time series (Fig. 2). In particular, abbreviating the interpulse interval length elevated ApEn independently of model choice, thereby denoting greater irregularity of subordinate subpatterns. Thus a pattern-sensitive statistic such as ApEn should offer a complementary means to discriminate among pulse trains with unequal mean pulsing frequencies, even when discrete peak detection would seem difficult (e.g., serum LH pulse profiles driven at higher frequencies; see Fig. 1). Indeed, the latter issue arises commonly in neurohormone tumoral secretion profiles, as exemplified by the adenomatous release of GH, ACTH, prolactin, and aldosterone (7, 18, 35, 39, 44, 45). Analogously, the highly irregular secretory output of GH in the female compared with male rat and human and of insulin and LH in aging and diabetic humans makes traditional peak identification difficult in these diverse settings (4, 14, 16, 24).

From the perspective of the experimentalist, the present pulse train simulations also highlight the relevance of appropriately chosen ApEn parameters and sampling intervals. First, in relation to ApEn comparison vector lengths (m = 1 and m = 2), subpattern reproducibility can be viewed as aggregating contiguous pair (m = 1) or triple (m = 2) distributions from an entropy-based perspective. As established earlier on empirical grounds, neurohormone time series of a typical length of 50-300 data points are often distinguished vividly by ApEn m = 1 (4, 7, 24, 27, 34, 39, 44, 53, 54, 58). In contrast, ApEn m >=  2 is relevant to discriminate more intensive and/or extended data series (19, 29, 30, 33). The ApEn contrasts observed here illustrate this analytic distinction. Second, in relation to choice of ApEn threshold (r, normalized as a percentage of the individual series SD), r less than two- to threefold of the within-sample random experimental variability discriminated pulsing differences with high reliability. Third, in relation to sampling frequency, simulations reinforced the importance of adequate sampling integrity of neurohormone pulse trains to distinguish series orderliness. This observation follows, inasmuch as ApEn is a family of regularity statistics parameterized on m and r, as well as N (series length). Accordingly, an earlier empirical analysis was used to define minimal series length(s) required to separate tumoral and normal GH and ACTH secretory patterns with high (75%) sensitivity and specificity (27). Given the complexity of secretory disruption in pathophysiology (5, 43), relevant simulation-based analyses may provide a complementary approach to mapping discriminative ApEn parameters in selected experimental and clinical contexts.

Further analyses corroborated an earlier finding and theoretical prediction of ApEn sensitivity to the convolved impulse-response (elimination) function. The mathematical basis for and biological implications of this relationship have been discussed (41). The present data corroborate the foregoing expectation in both low and high baseline regularity models. Accordingly, to the extent that secretory calculations do not introduce additional (technique dependent) variability in the derivative time series, applying ApEn to secretory output may enhance statistical contrasts. This inference was illustrated earlier by ApEn calculations of LH release profiles obtained by sampling the ovariectomized ewe at a central hypothalamopituitary portal site (to achieve predominantly secretion estimates) vs. a more peripheral jugular venous site (yielding an admixture of secretion, dilution, and elimination) (32).

The present biomathematical simulations of neurohormone pulse trains also establish that pulsing variability is an important non-frequency-dependent ApEn determinant. In the femalelike LH pulse model of highly regular baseline profiles (low initial ApEn), increased interpulse variability elevated ApEn progressively. In the malelike LH pulse model of more disorderly baseline release, increased pulse-to-pulse variability at any given mean pulse frequency, amplitude, or duration either had minimal effect on ApEn (for CV <30%) or reduced ApEn (for CV >30%). These platform-dependent features of ApEn evolution highlight the importance of primary physiological model structure. Clinical applications of ApEn likewise document system-specific ApEn contrasts in normal and pathological states; e.g., disease reduces ApEn of electrocardiographic and parathyroid hormone oscillations, whereas pathological secretion of LH, ACTH, GH, prolactin, cortisol, aldosterone, testosterone, and insulin elevates ApEn (2, 7-9, 11, 15, 22, 25, 27, 31, 34-39, 44, 45, 49, 53, 56, 58, 60-62). Whereas the present data do not bear directly on these diverse relationships, we can infer that the baseline state of model variables itself influences model output during strong perturbations.

The ApEn statistic quantifies the degree of order-dependent subpattern regularity in a time series (19, 23, 30). In addition, the variability of a particular pulse attribute (such as the amplitude, duration, or interpulse waiting time) can be considered in an order-independent manner, e.g., as designated by the CV of that parameter value. From an intuitive perspective, very high variability of (nonsuccessive) pulse amplitudes and/or interpulse intervals within an already disorderly time series (such as the malelike LH profiles simulated here) could confer greater ensemble regularity due to the occasional emergence of unusually large, wide, and/or more isolated pulses, manifesting the statistical bias discussed below.

Inasmuch as ApEn can discriminate the variability of pulse attributes in two series with comparable mean frequencies (above), we suggest that the mechanistic basis for pulsatility disruption in pathophysiology could be dissected further by quantifying the variability of discrete pulse features. For example, one could appraise both order-dependent (ApEn) and order-independent (CV of mean) variability of pulse amplitude and interpulse interval length in a time series. As illustrated in Fig. 7A, testosterone administration elevated ApEn of more disorderly 24-h serum GH concentration profiles in older but not young men without changing GH pulse frequency (3). Androgen treatment concurrently blunted GH pulse-mass variability (lower CV of the set of GH pulse-mass values) without changing GH interpulse interval variability [pooled mean ± SD (CV), 50 ± 4.9%]. In extension, the higher ApEn ratio of the ordered sequence of successive GH pulse-mass (but not interpulse interval) values induced by testosterone supplementation in older men uncovers heightened irregularity of ad seriatim pulse amplitudes (Fig. 7B). According to these insights, one might infer that exogenous testosterone in the aged male evokes greater nonuniformity of successive hypothalamic signaling inputs and/or pituitary somatotrope responsiveness, thereby explaining more disorderly patterns of GH roles.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 7.   A: reduced variability (lower CV) of 24-h (deconvolution estimated) growth hormone (GH) secretory pulse-mass values in healthy older (relative to young) men administered testosterone enanthate (200 mg im) weekly for 3 wk to stimulate pulsatile GH secretion (3). The latter intervention elevated ApEn of the serum GH concentration time series akin to the recognizably more irregular femalelike pattern of GH release in the rat and human (4, 5, 24, 54, 57) without altering GH secretory burst frequency (see DISCUSSION). B: increased irregularity (elevated ApEn ratios) of successive GH pulse-mass values in older men supplemented with testosterone as above (3). P values denote the results of unpaired parametric testing. Data are means ± SE (n = 8 subjects).

Perspectives

The primary message in this study is that one can infer a direct mechanistic relationship between parameter changes in a model of secretory dynamics and associated changes in output signal irregularity. Herein, we have used model parameter specifications based on two quite distinct LH secretory settings (emulating young men and midluteal women) to derive a number of such inferences. Most inferences were common to both settings, e.g., the ApEn increases with increasing half-life and with increasing pulse frequency. A few inferences were more state specific, e.g., the ApEn response to increased variability in burst amplitude or frequency. Although the choice of LH is strictly representative, we expect the aforementioned qualitative inferences to hold under much broader conditions, so that those conclusions common to both settings herein will hold under very general conditions, for a large plurality of hormones and physiological states. Conversely, in a few settings, it is imperative to know, at least qualitatively, the approximate state of the underlying physiological model to draw valid inferences between ApEn and parameter space.

We emphasize that the general qualitative conclusions drawn above (e.g., increasing half-life increases ApEn) should be interpreted as valid for models such as those used herein, and in likelihood for structurally similar models, but not necessarily for all model and network formulations. The putative utility of the preceding analysis is that the underlying model structure is a well-established first-order approximation of true hormonal dynamics and incorporates a number of biological properties and interrelationships that are (somewhat) specific to hormonal secretory dynamics. Thus the present paper goes beyond the more generically oriented and reductionist models, which link ApEn to its mechanistic relationship to parameter changes in broader, yet in some senses simpler, settings (20, 41).

The present model interpretations are consistent with those seen in previous studies under comparable settings, e.g., in comparing the effects of increasing pulse frequency and/or amplitude variation for a (somewhat) regular baseline time series. Our results using female LH simulations (Fig. 5A) are consistent with those of both Refs. 20 and 41 and with the general theme that increasing the SD of underlying pulse amplitude or frequencies increases ApEn given a low-to-moderate ApEn baseline.

Several statistical issues must be noted. Although generally ApEn with m = 1 and with m = 2 will provide similar qualitative findings, in some settings (e.g., series lengths N < 300 points) m = 1 is preferred, whereas for longer series (N > 300) m = 2 generally gives sharper distinctions. The tradeoffs, discussed more theoretically elsewhere (21, 26), are between the slightly greater reproducibility of ApEn with m = 1 for shorter series vs. the sharper probabilistic description provided by the m = 2 statistic. In statistical "boundary" contexts, this distinction is often relevant. Note that in Fig. 3A with the choice of r = 6% (a generally inappropriate r), the resultant m = 1 ApEn curve agrees more with the primary finding (as seen in the appropriate r = 20% panel). Similarly, in Fig. 3B, at 20-min simulated sampling, the m = 2 ApEn curve differs directionally from the 5- and 10-min sampling curves, reinforcing that for these sampling rates, m = 1 is the superior choice for valid statistical interpretation. However, in the vast majority of settings, including virtually all other figures here, the qualitative conclusions from m = 1 and m = 2 runs are common.

The relatively flat ApEn curves in Fig. 5B deserve special mention. In Fig. 5B, we investigated the effects on ApEn of increasing process variation (increasing pulse amplitude or frequency variation) atop a highly irregular ("males") baseline series and observed minimal ApEn change, except at extreme levels of variation. The technical issue is that data are already nearly maximally irregular (33); thus there is negligible statistical room for further ApEn increases, with a resultant apparent asymptote. This illustrates the consideration of limits of statistical resolution (19), i.e., for longer series lengths N, ApEn typically realizes finer parameter-space discrimination before an asymptote is apparent (19, 28). For longer series, the asymptotically maximal ApEn is higher, allowing a wider statistical interval between perfectly regular (ApEn = 0) and maximally irregular values. As a result, processes that exhibit minimal ApEn variation for changing parameter specifications with series of, e.g., N = 300 points often show significant distinctions based on longer (e.g., N > 1,000 point) series. This point is exemplified in a theoretical mathematical setting by an analysis of the composite oscillator noise MIX(p) stochastic process (Fig. 1 of Ref. 19). The message applied to the present analyses is that simulation of very long time series for the malelike models would also yield an increase in ApEn with increasing process variation, in contrast to the reported findings. We chose not to perform and report such large N studies because the intent here is to simulate an actual experimental data collection setting.

Finally, in Fig. 5B, we observe a slight yet apparent decrease in ApEn with increasing pulse variation, for very high (generally nonphysiological) levels of variation. This counterintuitive finding is again a statistical issue that vanishes for sufficiently longer time series at the same input levels of variation (30-100% CV). The decrease reflects a predicted bias effect; ApEn, like many classes of statistics, is a biased estimate of the true parameter (albeit asymptotically unbiased), as discussed in detail elsewhere (section VII of Ref. 21). The essential technical point is that certain conditional joint probability estimates from which ApEn is calculated by aggregation are not robustly estimated at shorter series lengths and very high levels of variation of input pulse characteristics. The ApEn values for such high-variation models remain replicable, i.e., there is a relatively small ApEn SD on evaluating multiple realizations for fixed parameter specifications. Thus, for a fixed series length (N), ApEn still discriminates among processes, even those with very high variation. The message is that to avoid potentially confounding interpretation, one should ensure that the underlying variation is not excessive or, alternatively, work with suitably long data series so that the bias effects are mitigated.

Within biology, ApEn is typically applied in physiological studies, wherein contrasting sets of data are well removed from nearly maximal ApEn values. In particular, virtually all hormonal secretory patterns under physiological conditions exhibit some measure of pulsatility, with a resultant ApEn value well below maximal. Thus the "asymptote issue" (see above) should rarely, if ever, interfere with the discriminatory function of ApEn. Moreover, with extremely high levels of pulse variation, system changes (from baseline) are dramatically evident by way of greatly increased values of the process SD.

In conclusion, the present analyses of simulated neurohormone pulse trains establish a mechanistic relationship between (changes in) multiple pulse characteristics and serial irregularity (ApEn) of resultant representative hormonal time series from a well-established, multiparameter model of secretory dynamics.


    ACKNOWLEDGEMENTS

We thank A. Chapin for assistance in manuscript preparation.


    FOOTNOTES

This work was supported in part by National Institutes of Health (NIH) Grant MO1-RR-00847 to the General Clinical Research Center of the University of Virginia Health Sciences Center, by National Institute of Child Health and Human Development/NIH Cooperative Agreement U-54-HD-28934 as part of the Specialized Cooperative Centers Program in Reproduction Research, and by NIH Grants RO1-AG-14799 (to J. D. Veldhuis) and SBIR-R44-DK-54104 (to S. M. Pincus). This focused report necessarily omits many primary references because of editorial constraints.

Address for reprint requests and other correspondence: J. D. Veldhuis, Div. of Endocrinology, Dept. of Internal Medicine, Univ. of Virginia School of Medicine, P.O. Box 800202, Charlottesville, VA 22908-0202 (E-mail: jdv{at}virginia.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 12 June 2001; accepted in final form 17 August 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Evans, WS, Sollenberger MJ, Booth RA, Jr, Rogol AD, Urban RJ, Carlsen EC, Johnson ML, and Veldhuis JD Contemporary aspects of discrete peak detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev 13: 81-104, 1992[ISI][Medline].

2.   Friend, K, Iranmanesh A, and Veldhuis JD. The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days. J Clin Endocrinol Metab 81: 3746-3753, 1996[Abstract].

3.  Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, and Veldhuis JD. Testosterone supplementation increases growth hormone secretion in older but not young men. Proc Endocr Soc 82nd Annual Mtg Toronto, Canada 1944, 2000.

4.   Gevers, E, Pincus SM, Robinson ICAF, and Veldhuis JD. Differential orderliness of the GH release process in castrate male and female rats. Am J Physiol Regulatory Integrative Comp Physiol 274: R437-R444, 1998[Abstract/Free Full Text].

5.   Giustina, A, and Veldhuis JD. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human. Endocr Rev 19: 717-797, 1998[Abstract/Free Full Text].

6.   Hartman, ML, Faria AC, Vance ML, Johnson ML, Thorner MO, and Veldhuis JD. Temporal structure of in vivo growth hormone secretory events in man. Am J Physiol Endocrinol Metab 260: E101-E110, 1991[Abstract/Free Full Text].

7.   Hartman, ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, and Veldhuis JD. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94: 1277-1288, 1994.

8.   Hindmarsh, PC, Dennison E, Pincus SM, Cooper C, Fall CH, Matthews DR, Pringle PJ, and Brook CG. A sexually dimorphic pattern of growth hormone secretion in the elderly. J Clin Endocrinol Metab 84: 2679-2685, 1999[Abstract/Free Full Text].

9.   Hollingdal, M, Juhl CB, Pincus SM, Sturis J, Veldhuis JD, Polonsky KS, Porksen N, and Schmitz O. Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes. Diabetes 49: 1334-1340, 2000[Abstract].

10.   Iranmanesh, A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, and Veldhuis JD. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth-hormone-releasing-hormone (GHRH) pulsatile infusion. Eur J Endocrinol 139: 59-71, 1998[Abstract].

11.   Kaplan, DT, Furman MI, Pincus SM, Ryan SM, Lipsitz LA, and Goldberger AL. Aging and the complexity of cardiovascular dynamics. Biophys J 59: 945-949, 1998[Abstract/Free Full Text].

12.   Keenan, DM, Sun W, and Veldhuis JD. A stochastic biomathematical model of the male reproductive hormone system. SIAM J Appl Math 61: 934-965, 2000.

13.   Keenan, DM, and Veldhuis JD. A biomathematical model of time-delayed feedback in the human male hypothalamic-pituitary-Leydig cell axis. Am J Physiol Endocrinol Metab 275: E157-E176, 1998[Abstract/Free Full Text].

14.   Keenan, DM, and Veldhuis JD. Explicating hypergonadotropism in postmenopausal women: a statistical model. Am J Physiol Regulatory Integrative Comp Physiol 278: R1247-R1257, 2000[Abstract/Free Full Text].

15.   Matt, DW, Kauma SW, Pincus SM, Veldhuis JD, and Evans WS. Characteristics of luteinizing hormone secretion in younger versus older premenopausal women. Am J Obstet Gynecol 178: 504-510, 1998[ISI][Medline].

16.   Meneilly, GS, Veldhuis JD, and Elahi D. Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab 84: 1938-1943, 1999[Abstract/Free Full Text].

17.   Ovesen, P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, and Jorgensen JO. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the preovulatory interval in normal women. J Clin Endocrinol Metab 83: 1662-1667, 1998[Abstract/Free Full Text].

18.   Painson, JC, Veldhuis JD, and Tannenbaum GS. Single exposure to testosterone in adulthood rapidly induces regularity in the growth hormone release process. Am J Physiol Endocrinol Metab 278: E933-E940, 2000[Abstract/Free Full Text].

19.   Pincus, SM. Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA 88: 2297-2301, 1991[Abstract/Free Full Text].

20.   Pincus, SM. Greater signal regularity may indicate increased system isolation. Math Biosci 122: 161-181, 1994[ISI][Medline].

21.   Pincus, SM. Approximate entropy (ApEn) as a complexity measure. Chaos 5: 110-117, 1995[ISI][Medline].

22.   Pincus, SM. Quantifying complexity and regularity of neurobiological systems. Methods Neurosci 28: 336-363, 1995.

23.   Pincus, SM. Irregularity and asynchrony in biologic network signals. Methods Enzymol 321: 149-182, 2000[ISI][Medline].

24.   Pincus, SM, Gevers EF, Robinson IC, van den Berg G, Roelfsema F, Hartman ML, and Veldhuis JD. Females secrete growth hormone with more process irregularity than males in both human and rat. Am J Physiol Endocrinol Metab 270: E107-E115, 1996[Abstract/Free Full Text].

25.   Pincus, SM, Gladstone IM, and Ehrenkranz RA. A regularity statistic for medical data analysis. J Clin Monit 7: 335-345, 1991[ISI][Medline].

26.   Pincus, SM, and Goldberger AL. Physiological time-series analysis: what does regularity quantify? Am J Physiol Heart Circ Physiol 266: H1643-H1656, 1994[Abstract/Free Full Text].

27.   Pincus, SM, Hartman ML, Roelfsema F, Thorner MO, and Veldhuis JD. Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol Endocrinol Metab 277: E948-E957, 1999[Abstract/Free Full Text].

28.   Pincus, SM, and Huang WM. Approximate entropy: statistical properties and applications. Commun Statist Theory Meth 21: 3061-3077, 1992.

29.   Pincus, SM, and Kalman RE. Not all (possibly) "random" sequences are created equal. Proc Natl Acad Sci USA 94: 3513-3518, 1997[Abstract/Free Full Text].

30.   Pincus, SM, and Keefe DL. Quantification of hormone pulsatility via an approximate entropy algorithm. Am J Physiol Endocrinol Metab 262: E741-E754, 1992[Abstract/Free Full Text].

31.   Pincus, SM, Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, and Veldhuis JD. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci USA 93: 14100-14105, 1996[Abstract/Free Full Text].

32.   Pincus, SM, Padmanabhan V, Lemon W, Randolph J, and Midgley AR. FSH is secreted more irregularly than LH in both human and sheep. J Clin Invest 101: 1318-1324, 1998[ISI][Medline].

33.   Pincus, SM, and Singer BH. Randomness and degrees of irregularity. Proc Natl Acad Sci USA 93: 2083-2088, 1996[Abstract/Free Full Text].

34.   Pincus, SM, Veldhuis JD, Mulligan T, Iranmanesh A, and Evans WS. Effects of age on the irregularity of LH and FSH serum concentrations in women and men. Am J Physiol Endocrinol Metab 273: E989-E995, 1997[Abstract/Free Full Text].

35.   Roelfsema, F, Pincus SM, and Veldhuis JD. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects. J Clin Endocrinol Metab 83: 688-692, 1998[Abstract/Free Full Text].

36.   Schmitt, CP, Huber D, Mehls O, Maiwald J, Stein G, Veldhuis JD, Ritz E, and Schaefer F. Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism. J Am Soc Nephrol 9: 1832-1844, 1998[Abstract].

37.   Schmitt, CP, Schaefer F, Bruch A, Veldhuis JD, Schmidt-Gayk H, Stein G, Ritz E, and Mehls O. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. J Clin Endocrinol Metab 81: 4236-4243, 1996[Abstract].

38.   Schmitz, O, Porksen N, Nyholm B, Skjaerbaek C, Butler PC, Veldhuis JD, and Pincus SM. Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. Am J Physiol Endocrinol Metab 272: E218-E226, 1997[Abstract/Free Full Text].

39.   Siragy, HM, Vieweg WVR, Pincus SM, and Veldhuis JD. Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism. J Clin Endocrinol Metab 80: 28-33, 1995[Abstract].

40.   Sollenberger, ML, Carlson EC, Johnson ML, Veldhuis JD, and Evans WS. Specific physiological regulation of LH secretory events throughout the human menstrual cycle: new insights into the pulsatile mode of gonadotropin release. J Neuroendocrinol 2: 845-852, 1990.

41.   Sparacino, G, Bardi F, and Cobelli C. Approximate entropy studies of hormone pulsatility from plasma concentration time series: influence of the kinetics assessed by stimulation. Ann Biomed Eng 28: 665-676, 2000[ISI][Medline].

42.   Trunet, PF, Mueller PH, Bhatnagar AS, Dickes I, Monnet G, and White G. Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 67, in healthy male subjects. J Clin Endocrinol Metab 77: 319-323, 1993[Abstract].

43.   Urban, RJ, Evans WS, Rogol AD, Kaiser DL, Johnson ML, and Veldhuis JD. Contemporary aspects of discrete peak detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev 9: 3-37, 1988[ISI][Medline].

44.   Van den Berg, G, Pincus SM, Frolich M, Veldhuis JD, and Roelfsema F. Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol 138: 164-169, 1998[Abstract].

45.   Van den Berg, G, Pincus SM, Veldhuis JD, Frolich M, and Roelfsema F. Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease. Eur J Endocrinol 136: 394-400, 1997[Abstract].

46.   Veldhuis, JD. The neuroendocrine control of ultradian rhythms. In: Neuroendocrinology in Physiology and Medicine, edited by Conn PM, and Freeman M.. Totowa, NJ: Humana, 1999, p. 453-472.

47.   Veldhuis, JD, Carlson ML, and Johnson ML. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84: 7686-7690, 1987[Abstract/Free Full Text].

48.   Veldhuis, JD, Fraioli F, Rogol AD, and Dufau ML. Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest 77: 1122-1128, 1986.

49.   Veldhuis, JD, Iranmanesh A, Mulligan T, and Pincus SM. Disruption of the young-adult synchrony between luteinizing hormone release and oscillations in follicle-stimulating hormone, prolactin, and nocturnal penile tumescence (NPT) in healthy older men. J Clin Endocrinol Metab 84: 3498-3505, 1999[Abstract/Free Full Text].

50.   Veldhuis, JD, and Johnson ML. Deconvolution analysis of hormone data. Methods Enzymol 210: 539-575, 1992[ISI][Medline].

51.   Veldhuis, JD, Johnson ML, and Dufau ML. Physiological attributes of endogenous bioactive luteinizing hormone secretory bursts in man: assessment by deconvolution analysis and in vitro bioassay of LH. Am J Physiol Endocrinol Metab 256: E199-E207, 1989[Abstract/Free Full Text].

52.   Veldhuis, JD, Lassiter AB, and Johnson ML. Operating behavior of dual or multiple endocrine pulse generators. Am J Physiol Endocrinol Metab 259: E351-E361, 1990[Abstract/Free Full Text].

53.   Veldhuis, JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S, Straume M, and Iranmanesh A. Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80: 3209-3222, 1995[Abstract].

54.   Veldhuis, JD, Metzger DL, Martha PM, Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD, and Pincus SM. Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82: 3414-3420, 1997[Abstract/Free Full Text].

55.   Veldhuis, JD, Moorman J, and Johnson ML. Deconvolution analysis of neuroendocrine data: waveform-specific and waveform-independent methods and applications. Methods Neurosci 20: 279-325, 1994.

56.   Veldhuis, JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, and Barontini M. Disruption of the joint synchrony of luteinizing hormone, testosterone and androstenedione secretion in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 86: 72-79, 2001[Abstract/Free Full Text].

57.   Veldhuis, JD, Roemmich JN, and Rogol AD. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth-hormone (GH) secretion in prepubertal and late adolescent males and females. J Clin Endocrinol Metab 85: 2385-2394, 2000[Abstract/Free Full Text].

58.   Veldhuis, JD, Straume M, Iranmanesh A, Mulligan T, Jaffe C, Barkan A, Johnson ML, and Pincus S. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol Regulatory Integrative Comp Physiol 280: R721-R729, 2001[Abstract/Free Full Text].

59.   Veldhuis, JD, Urban RJ, Lizarralde G, Johnson ML, and Iranmanesh A. Attenuation of luteinizing hormone secretory burst amplitude is a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 75: 52-58, 1992.

60.   Veldman, RG, Frolich M, Pincus SM, Veldhuis JD, and Roelfsema F. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy. J Clin Endocrinol Metab 85: 4039-4046, 2000[Abstract/Free Full Text].

61.   Veldman, RG, Frolich M, Pincus SM, Veldhuis JD, and Roelfsema F. Basal, pulsatile, entropic and twenty-four-hours rhythmic features of secondary hyperprolactinemia due to functional pituitary-stalk disconnection fully mimic tumoral (primary) hyperprolactinemia. J Clin Endocrinol Metab 86: 1562-1567, 2001[Abstract/Free Full Text].

62.   Veldman, RG, van den Berg G, Pincus SM, Frolich M, Veldhuis JD, and Roelfsema F. Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrinol 140: 192-200, 1999[Abstract].


Am J Physiol Regul Integr Comp Physiol 281(6):R1975-R1985
0363-6119/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Y. Liu, A. Iranmanesh, D. M. Keenan, S. M. Pincus, and J. D. Veldhuis
A noninvasive measure of negative-feedback strength, approximate entropy, unmasks strong diurnal variations in the regularity of LH secretion
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1409 - E1415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Y. Liu, S. M. Pincus, P. Y. Takahashi, P. D. Roebuck, A. Iranmanesh, D. M. Keenan, and J. D. Veldhuis
Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E34 - E41.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Y. Liu, S. M. Pincus, D. M. Keenan, F. Roelfsema, and J. D. Veldhuis
Analysis of bidirectional pattern synchrony of concentration-secretion pairs: implementation in the human testicular and adrenal axes
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R440 - R446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. O. van Aken, A. M. Pereira, M. Frolich, J. A. Romijn, H. Pijl, J. D. Veldhuis, and F. Roelfsema
Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E63 - E70.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. W. Kok, F. Roelfsema, S. Overeem, G. J. Lammers, M. Frolich, A. E. Meinders, and H. Pijl
Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men
Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E630 - E636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. R. Biermasz, A. M. Pereira, M. Frolich, J. A. Romijn, J. D. Veldhuis, and F. Roelfsema
Octreotide represses secretory-burst mass and nonpulsatile secretion but does not restore event frequency or orderly GH secretion in acromegaly
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E25 - E30.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. M. Keenan, W. S. Evans, and J. D. Veldhuis
Control of LH secretory-burst frequency and interpulse-interval regularity in women
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E938 - E948.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. S. Farhy and J. D. Veldhuis
Joint pituitary-hypothalamic and intrahypothalamic autofeedback construct of pulsatile growth hormone secretion
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1240 - R1249.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Keenan, F. Roelfsema, N. Biermasz, and J. D. Veldhuis
Physiological control of pituitary hormone secretory-burst mass, frequency, and waveform: a statistical formulation and analysis
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R664 - R673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. E. Lake, J. S. Richman, M. P. Griffin, and J. R. Moorman
Sample entropy analysis of neonatal heart rate variability
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R789 - R797.
[Abstract] [Full Text] [PDF]


This Article